U.S. Pharmaceutical companies and the Food and Drug Administration (FDA) could soon track prescription drugs over an interoperable blockchain as a means to detect and put an end to counterfeit medicines in the market.
不久之后，美国的制药商和美国食品和药物管理局（FDA）就可以通过可互操作的区块链追踪处方药，从而检测并打击市场上的假冒药品。
The solution comes from San Francisco-based blockchain startup Chronicled and its partnership with LInkLab, a life sciences supply chain. The two companies have launched a blockchain“track and trace” pilot at a recent one-day event in San Francisco. Developed for the pharmaceutical industry, the solution could prove a viable means to curbing counterfeit drug distribution and sales in the United States and beyond.
该解决方案由来自旧金山的区块链初创公司Chronicled与生命科学供应链LinkLab合作开发。近日，两家公司在旧金山发起了为期一天的“追踪定位”（track and trace）试验。该解决方案专为制药行业开发，或将是在美国及其他地区打击假冒药品分销出售的一种可行方式。
Attended by representatives from global pharma manufacturers, wholesalers and hospitals, the blockchainpilot event also saw participation from enterprise IT giants and blockchain tech companies. The event, according to Chronicled, marks the first phase of a pilot to develop an interoperable blockchain platform for the pharmaceutical industry.
参与此次区块链试验活动的不仅有全球各地的制药商、批发商和医院的代表，还有企业级IT巨头和区块链科技公司。这次活动标志着制药行业可互操作区块链平台开发试验进入第一阶段。
The blockchainplatform will adhere and satisfy the FDA’s Drug Supply Chain Security Act, signed into effect by former US President Obama in November 2013. The act was and signed to“develop an electronic, interoperable system to identify and trace certain prescription drugs as they are distributed in the United States.“
该区块链平台将遵守FDA的《药物供应链安全法》（DSCSA，Drug Supply Chain Security Act），这是由前美国总统奥巴马于2013年11月签署生效的。该法案旨在“开发电子互操作系统来识别和追踪在全国各地进行分销的某些处方药。”
More details——详情请点击“阅读原文”
最新云策科技资讯，敬请关注New World Innovations云策科技集团微信公告号
或登陆 www.nwino.net云策科技集团官网查询详细信息